CD274 and neoplasm: Taken together, these effects account for the reason why the first line of platinum-based therapies, DNA-synthesis inhibitors, and extensive immunotherapies, including checkpoint-blockers, did not work for Patient# 3, although we see a high PD-L1 expressed in the cells derived from the patient’s tumor.